These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21598817)

  • 21. Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.
    Mackay HJ; McGee J; Villa D; Gubbay JB; Tinker LM; Shi L; Kuruvilla J; Wang L; MacAlpine K; Oza AM
    J Clin Virol; 2011 Mar; 50(3):212-6. PubMed ID: 21168361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute transverse myelitis secondary to hepatitis B vaccination].
    Iñiguez C; Mauri JA; Larrodé P; López del Val J; Jericó I; Morales F
    Rev Neurol; 2000 Sep 1-15; 31(5):430-2. PubMed ID: 11027094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AS03(A)-Adjuvanted influenza A (H1N1) 2009 vaccine for adults up to 85 years of age.
    Roman F; Vaman T; Kafeja F; Hanon E; Van Damme P
    Clin Infect Dis; 2010 Sep; 51(6):668-77. PubMed ID: 20687838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
    Loebermann M; Anders G; Brestrich G; Fritzsche C; Klammt S; Boršo D; Frimmel S; Riebold D; Reisinger EC
    Vaccine; 2011 Feb; 29(6):1228-34. PubMed ID: 21167116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactivation of acute retinal necrosis after flu H1N1 vaccination.
    Rothova A; de Groot JD; Mudrikova T
    Br J Ophthalmol; 2011 Feb; 95(2):291. PubMed ID: 20733030
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
    Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
    Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vaccine update 2009: questions around the safety of the influenza A (H1N1) vaccine].
    Siegrist CA
    Rev Med Suisse; 2010 Jan; 6(231):67-70. PubMed ID: 20196437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of nephrotic syndrome following the use of 2009 pandemic influenza A (H1N1) vaccine.
    Fernandes P; Jorge S; Lopes JA
    Am J Kidney Dis; 2010 Jul; 56(1):185-6. PubMed ID: 20620684
    [No Abstract]   [Full Text] [Related]  

  • 29. Adverse effects following pandemic influenza (H1N1) 2009 vaccination.
    Bolam B; Grills N
    Aust N Z J Public Health; 2009 Dec; 33(6):584. PubMed ID: 20078579
    [No Abstract]   [Full Text] [Related]  

  • 30. New findings on H1N1 vaccine prompt revised prescribing advice.
    Watts G
    BMJ; 2011 Apr; 342():d2524. PubMed ID: 21502262
    [No Abstract]   [Full Text] [Related]  

  • 31. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
    Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
    Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2009 H1N1 influenza vaccines in pregnant women: the French Pharmacovigilance survey.
    Lacroix I; Damase-Michel C; Kreft-Jais C; Castot A; Montastruc JL;
    Vaccine; 2011 Feb; 29(7):1357-8. PubMed ID: 21185422
    [No Abstract]   [Full Text] [Related]  

  • 33. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monovalent influenza A(H1N1) vaccine, 1986-1987. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Nov; 105(5):737-9. PubMed ID: 3021040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety of the H1N1 influenza A vaccine in egg allergic individuals.
    Greenhawt MJ; Chernin AS; Howe L; Li JT; Sanders G
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):387-93. PubMed ID: 21055666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and tolerability of a virosome influenza vaccine compared to split influenza vaccine in patients with sickle cell anemia.
    Souza AR; Braga JA; de Paiva TM; Loggetto SR; Azevedo RS; Weckx LY
    Vaccine; 2010 Jan; 28(4):1117-20. PubMed ID: 20116631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009.
    McVernon J; Nolan T
    Expert Rev Vaccines; 2011 Jan; 10(1):35-43. PubMed ID: 21162618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swine flu vaccine is a "thousandfold" safer than the infection, say experts.
    Ellis O
    BMJ; 2009 Sep; 339():b3802. PubMed ID: 19759084
    [No Abstract]   [Full Text] [Related]  

  • 39. [Egg allergy and vaccine against the new influenza. A plan of action in Ostergotland].
    Kronander UN; Nilsson L
    Lakartidningen; 2009 Nov 25-Dec 1; 106(48):3230. PubMed ID: 20101832
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical pearls for H1N1 influenza vaccination.
    Marcotte GV
    J Allergy Clin Immunol; 2010 Apr; 125(4):951-2; author reply 952. PubMed ID: 20226509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.